MENU
EVMN
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Evommune (EVMN) Earnings Date & Reports
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases... Show more
A.I. Advisor
published Earnings
EVMN is expected to report earnings to fall 7.87% to -81 cents per share on December 10
Q3'26
Est.
$-0.82
Q2'26
Missed
by $0.20
Q1'26
Beat
by $0.12
The last earnings report on August 07 showed earnings per share of -88 cents, missing the estimate of -68 cents. With 78.76K shares outstanding, the current market capitalization sits at 187.63M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
1841 Page Mill Road
Phone
+1 925 247-4481
Employees
48
Web
https://www.evommune.com